Cediranib
Showing 76 - 92 of 92
Cancer Trial in United Kingdom (Cediranib, Cediranib 30 - 90 mg)
Completed
- Cancer
- Cediranib
- Cediranib 30 - 90 mg
-
Glasgow, United Kingdom
- +3 more
Oct 3, 2012
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (cediranib maleate, laboratory
Completed
- B-cell Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- cediranib maleate
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Jan 14, 2013
Cancer Trial in London (Recentin (Cediranib))
Completed
- Cancer
- Recentin (Cediranib)
-
London, United KingdomResearch Site
Jun 30, 2011
Advanced Solid Malignancies Trial in Beijing, Hong Kong (cediranib (RECENTIN TM, AZD2171))
Completed
- Advanced Solid Malignancies
- cediranib (RECENTIN TM, AZD2171)
-
Beijing, Beijing, China
- +1 more
Jun 17, 2011
Gastric Cancer Trial in Japan (Cediranib, Cisplatin, S-1)
Completed
- Gastric Cancer
- Cediranib
- +3 more
-
Nagoya, Aichi, Japan
- +3 more
Jun 13, 2011
Advanced Solid Tumors Trial in Canada, Denmark (cediranib (RECENTIN TM, AZD2171))
Completed
- Advanced Solid Tumors
- cediranib (RECENTIN TM, AZD2171)
-
Hamilton, Canada
- +4 more
Mar 9, 2011
Advanced Solid Tumor, Liver Metastases Trial in Freiburg (AZD2171)
Completed
- Advanced Solid Tumor
- Liver Metastases
-
Freiburg, GermanyResearch Site
Jan 20, 2011
Recurrent Glioblastoma, Brain Tumor Trial in Boston, Sutton (Cediranib, Lomustine)
Completed
- Recurrent Glioblastoma
- Brain Tumor
- Cediranib
- Lomustine
-
Boston, Massachusetts
- +1 more
Nov 24, 2009